Differential expression of “A Disintegrin and Metalloproteinase 10” in hepatocellular carcinoma and the noncancerous hepatic tissues: Contribution to HCV-promoted hepatocarcinogenesis
Background: A disintegrin and metalloproteinases (ADAMs) have emerged as therapeutic targets in many cancers. ADAM10 was particularly studied in hepatocellular carcinoma (HCC) for its potential role in hepatocarcinogenesis and HCC progression. Objective: To investigate the immunohistochemical (IHC)...
Saved in:
Main Authors: | Amal Abd El Hafez, Basem H. Elesawy, Heba S. E. I. Hany |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2023-07-01
|
Series: | Indian Journal of Pathology and Microbiology |
Subjects: | |
Online Access: | https://journals.lww.com/10.4103/ijpm.ijpm_608_21 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A disintegrin and metallopeptidase domain (ADAM) 12, ADAM 17 mRNA and ADAM10 protein hold potential as biomarkers for detection of early gastric cancer
by: Sooyeon Oh, et al.
Published: (2025-01-01) -
Hepatocellular carcinoma in a sheep
by: Zabid Yener, et al. -
Fine Tuning Cell Migration by a Disintegrin and Metalloproteinases
by: D. Dreymueller, et al.
Published: (2017-01-01) -
Autophagy-related long non-coding RNA MIR210HG plays a therapeutic role in hepatocellular carcinoma
by: Chaoqun Zhang, et al.
Published: (2025-01-01) -
TMEM101 expression and its impact on immune cell infiltration and prognosis in hepatocellular carcinoma
by: Lingyun Kuang, et al.
Published: (2024-12-01)